Human E2F-1 reactivates cell cycle progression in ventricular myocytes and represses cardiac gene transcription

110Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The 'pocket' protein- and p300-binding domains of E1A mediate alternative pathways that, independently, provoke S phase reentry in ventricular muscle cells and repress cardiac-specific transcription. In the present study, we utilized recombinant adenovirus to deliver mammalian E2F-1, whose release from pocket proteins may underlie effects of E1A and mitogenic signaling. Like E1A, E2F-1 proved cytotoxic in the absence of E1B. Used along with E1B to avert apoptosis, E2F-1 inhibited the cardiac and skeletal α-actin promoters, serum response factor abundance, and sarcomeric actin biosynthesis, while inducing DNA synthesis and proliferating cell nuclear antigen. Image analysis of Feulgen-stained nuclei corroborated a parallel increase in DNA content, with accumulation in G2/M. Thus, E2F-1 suffices for all observed actions of E1A in cardiac myocytes.

Cite

CITATION STYLE

APA

Kirshenbaum, L. A., Abdellatif, M., Chakraborty, S., & Schneider, M. D. (1996). Human E2F-1 reactivates cell cycle progression in ventricular myocytes and represses cardiac gene transcription. Developmental Biology, 179(2), 402–411. https://doi.org/10.1006/dbio.1996.0270

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free